The Mediterranean diet tracks with tiny proteins that may guard the heart

The Mediterranean diet has an unusually strong evidence base, with benefits shown in both observational studies and randomised controlled trials, yet how it actually works inside cells is still being pieced together. One emerging idea is that the diet acts partly through mitochondria, the energy-producing structures in our cells. Mitochondrial DNA encodes tiny proteins called microproteins, which have been shown to regulate ageing, cardiometabolic function and neuroprotection. If eating pattern tracks with levels of these microproteins, they could serve both as biomarkers of the diet and as pointers to new mechanisms of heart protection.

Researchers ran a cross-sectional analysis of 49 patients, averaging 78.4 years old and 57% female, drawn from an observational study of non-valvular atrial fibrillation at Sapienza University of Rome. Adherence to the Mediterranean diet was scored with a 9-item questionnaire, splitting participants into low-medium (0 to 6) and high (7 to 9) adherence groups. Circulating levels of the microproteins Humanin and SHMOOSE were measured with an in-house assay. Oxidative stress was gauged through two blood markers, a soluble Nox2-derived peptide and 8-iso-prostaglandin F2α.

The 20 patients with high adherence, 40.8% of the sample, had significantly higher plasma levels of both SHMOOSE and Humanin than the 29 with low-medium adherence. Looking at individual foods, SHMOOSE was higher with greater olive oil consumption and lower intake of refined bread, while Humanin correlated positively with olive oil, fish and legumes. Humanin was also inversely associated with the Nox2-derived oxidative stress marker, a link that held after adjusting for sex and body mass index, and with 8-iso-prostaglandin F2α. The authors read this as possible crosstalk between Humanin signalling and Nox2 activity, a candidate cardioprotective mechanism.

This extends the Mediterranean diet literature into mitochondrial biology, proposing microproteins as potential mediators of the diet's benefits and as biomarkers for tailoring nutrition in older age. It is a snapshot, though: diet and protein levels were measured at the same moment, so the study cannot say whether the diet raises these microproteins or whether something else explains both. The sample was small, elderly and drawn from heart-rhythm patients, which limits how widely the pattern applies. The authors themselves call for further work to establish mechanism and causality.

For a reader already persuaded by the Mediterranean diet's broader evidence, this is a glimpse of what might be happening under the bonnet rather than a new reason to eat differently. It is notable that the foods most tied to the microproteins here were olive oil, fish and legumes, the pattern's signature ingredients. But an association in 49 older patients does not prove the diet raises these proteins, let alone that doing so protects the heart. Worth filing as an early mechanistic clue to watch.